Homology Medicines Inc
FIXX
Market Cap$3.02M
Close$
$-0.34
136.7% downside
Current Fair Value
136.7% downsideOvervalued by 136.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.02 Million |
|---|---|
| Enterprise Value | $-103,303,255.00 |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-351.57 |
| Beta | -0.11 |
| Outstanding Shares | 995,280 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.01 |
|---|---|
| PEG | 0.01 |
| Price to Sales | 0.93 |
| Price to Book Ratio | 0.02 |
| Enterprise Value to Revenue | -58.3 |
| Enterprise Value to EBIT | 1.21 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | -0.09 |
| Debt to Equity | 0.19 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Homology Medicines Inc
CEO: Arthur Tzianabos